Skip to main content
Log in

Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Type 2 Diabetes: A New Imaging Possibility and a New Biomarker

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

We performed a cross-sectional study to investigate the prevalence of Diffuse Idiopathic Skeletal Hyperostosis (DISH) through Dual-Energy X-ray absorptiometry (DXA) Vertebral Fracture Assessment (VFA) in a group of post-menopausal women with Type 2 Diabetes Mellitus (T2DM). We also explored several biomarkers of bone turnover metabolism, including Wnt pathway modulators. DXA-VFA was performed to detect the presence of DISH. Serum samples were collected from all patients at the time of study recruitment. 16 different serum biomarkers were tested between the two subgroups. Given the exploratory nature of the study, we did not adjust for multiplicity. At VFA analysis, among 96 individuals enrolled in the study 20 (20.8%) showed features of DISH. No statistically significant difference was found for BMD values, between the DISH and NO-DISH subgroups. Concerning blood biomarkers, DISH patients showed a significant difference only in the sclerostin serum levels (32 vs 35.5 pmol/L, for the DISH and NO-DISH subgroup, respectively; p = 0.010). After adjustment for confounding factors, sclerostin serum levels remained significantly lower in DISH group (p = 0.002). We demonstrated a non-negligible prevalence of DISH in a population of post-menopausal women affected by T2DM and suggested low serum sclerostin as a possible key feature associated with DISH presence. In addition, we propose DXA-VFA analysis, whose radiation dose is considerably lower than conventional radiography, as a viable diagnostic and prognostic mean to obtain data not only on bone health, but also for the screening for DISH in subjects at risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of Data and Materials

The dataset used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

SD:

Standard deviation

BMI:

Body mass index

HbA1c:

Glycated hemoglobin

hsCRP:

High-sensitivity C-reactive protein

PTH:

Parathyroid hormone

CTX:

C-terminal cross-linking telopeptide of type 1 collagen

PINP:

Serum procollagen type 1 N-terminal propeptide

Dkk-1:

Dickkopf-1

RANKL:

Receptor activator of nuclear factor kappa-Β ligand

25(OH)D:

25-Hydroxyvitamin D

LDL:

Low-density lipoprotein

HDL:

High-density lipoprotein

HOMA-IR:

Homeostatic Model Assessment for Insulin Resistance

FFM:

Fat-free mass

FM:

Fat mass

BMD:

Bone mass density

T2DM:

Type 2 diabetes mellitus

DISH:

Diffuse idiopathic skeletal hyperostosis

DXA:

Dual-energy X-ray absorptiometry

CI:

Confidence interval

IQR:

Interquartile range

References

  1. Mader R, Verlaan J-J, Buskila D (2013) Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nat Rev Rheumatol 9:741–750. https://doi.org/10.1038/nrrheum.2013.165

    Article  PubMed  Google Scholar 

  2. Littlejohn GO, Smythe HA (1981) Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8:965–968

    CAS  PubMed  Google Scholar 

  3. Mueller MB, Blunk T, Appel B et al (2013) Insulin is essential for in vitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner. Int Orthop 37:153–158. https://doi.org/10.1007/s00264-012-1726-z

    Article  PubMed  Google Scholar 

  4. Akune T, Ogata N, Seichi A et al (2001) Insulin secretory response is positively associated with the extent of ossification of the posterior longitudinal ligament of the spine. J Bone Jt Surg Am 83:1537–1544. https://doi.org/10.2106/00004623-200110000-00013

    Article  CAS  Google Scholar 

  5. Belanger TA, Rowe DE (2001) Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg 9:258–267. https://doi.org/10.5435/00124635-200107000-00006

    Article  CAS  PubMed  Google Scholar 

  6. Rossini M, Gatti D, Adami S (2013) Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121–132. https://doi.org/10.1007/s00223-013-9749-z

    Article  CAS  PubMed  Google Scholar 

  7. Gennari L, Merlotti D, Valenti R et al (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 97:1737–1744. https://doi.org/10.1210/jc.2011-2958

    Article  CAS  PubMed  Google Scholar 

  8. Mantovani A, Sani E, Fassio A et al (2019) Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab 45:347–355. https://doi.org/10.1016/j.diabet.2018.10.001

    Article  CAS  PubMed  Google Scholar 

  9. Senolt L, Hulejova H, Krystufkova O et al (2012) Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Ann Rheum Dis 71:71–74. https://doi.org/10.1136/annrheumdis-2011-200357

    Article  CAS  PubMed  Google Scholar 

  10. Diacinti D, Del Fiacco R, Pisani D et al (2012) Diagnostic performance of vertebral fracture assessment by the lunar iDXA scanner compared to conventional radiography. Calcif Tissue Int 91:335–342. https://doi.org/10.1007/s00223-012-9643-0

    Article  CAS  PubMed  Google Scholar 

  11. Duboeuf F, Bauer DC, Chapurlat RD et al (2005) Assessment of vertebral fracture using densitometric morphometry. J Clin Densitom 8:362–368. https://doi.org/10.1385/jcd:8:3:362

    Article  CAS  PubMed  Google Scholar 

  12. Chapurlat RD, Duboeuf F, Marion-Audibert HO et al (2006) Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture. Osteoporos Int 17:1189–1195. https://doi.org/10.1007/s00198-006-0121-2

    Article  CAS  PubMed  Google Scholar 

  13. Diacinti D, Guglielmi G (2010) Vertebral morphometry. Radiol Clin North Am 48:561–575. https://doi.org/10.1016/j.rcl.2010.02.018

    Article  PubMed  Google Scholar 

  14. Blake GM, Rea JA, Fogelman I (1997) Vertebral morphometry studies using dual-energy X-ray absorptiometry. Semin Nucl Med 27:276–290. https://doi.org/10.1016/S0001-2998(97)80029-3

    Article  CAS  PubMed  Google Scholar 

  15. Mader R, Lavi I (2009) Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartil 17:825–828. https://doi.org/10.1016/j.joca.2008.12.004

    Article  CAS  Google Scholar 

  16. Sencan D, Elden H, Nacitarhan V et al (2005) The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int 25:518–521. https://doi.org/10.1007/s00296-004-0474-9

    Article  CAS  PubMed  Google Scholar 

  17. Kiss C, Szilágyi M, Paksy A, Poór G (2002) Risk factors for diffuse idiopathic skeletal hyperostosis: a case–control study. Rheumatol Oxf Engl 41:27–30. https://doi.org/10.1093/rheumatology/41.1.27

    Article  CAS  Google Scholar 

  18. Fassio A, Rossini M, Viapiana O et al (2017) New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application. Curr Pharm Des 23:6241–6250. https://doi.org/10.2174/1381612823666170713104431

    Article  CAS  PubMed  Google Scholar 

  19. Fassio A, Idolazzi L, Viapiana O et al (2017) In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls. Clin Rheumatol 36:2377–2381. https://doi.org/10.1007/s10067-017-3734-2

    Article  PubMed  Google Scholar 

  20. Fassio A, Adami G, Gatti D et al (2018) Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators. Int Immunopharmacol 67:487–489. https://doi.org/10.1016/j.intimp.2018.12.050

    Article  CAS  PubMed  Google Scholar 

  21. Rossini M, Viapiana O, Adami S et al (2015) In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol 33:77–83

    PubMed  Google Scholar 

  22. Baron R, Gori F (2018) Targeting WNT signaling in the treatment of osteoporosis. Curr Opin Pharmacol 40:134–141. https://doi.org/10.1016/j.coph.2018.04.011

    Article  CAS  PubMed  Google Scholar 

  23. Adami G, Orsolini G, Adami S et al (2016) Effects of TNF inhibitors on parathyroid hormone and Wnt signaling antagonists in rheumatoid arthritis. Calcif Tissue Int 99:360–364. https://doi.org/10.1007/s00223-016-0161-3

    Article  CAS  PubMed  Google Scholar 

  24. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444. https://doi.org/10.1007/s00198-006-0253-4

    Article  CAS  PubMed  Google Scholar 

  25. Yang S, Shen X (2015) Association and relative importance of multiple obesity measures with bone mineral density: the National Health and Nutrition Examination Survey 2005–2006. Arch Osteoporos 10:14. https://doi.org/10.1007/s11657-015-0219-2

    Article  PubMed  Google Scholar 

  26. Glick K, Novofastovski I, Schwartz N, Mader R (2020) Cardiovascular disease in diffuse idiopathic skeletal hyperostosis (DISH): from theory to reality-a 10-year follow-up study. Arthritis Res Ther 22:190. https://doi.org/10.1186/s13075-020-02278-w

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hiyama A, Katoh H, Sakai D et al (2018) Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) assessed with whole-spine computed tomography in 1479 subjects. BMC Musculoskelet Disord 19:178. https://doi.org/10.1186/s12891-018-2108-5

    Article  PubMed  PubMed Central  Google Scholar 

  28. Mori K, Kasahara T, Mimura T et al (2017) Prevalence of thoracic diffuse idiopathic skeletal hyperostosis (DISH) in Japanese: results of chest CT-based cross-sectional study. J Orthop Sci 22:38–42. https://doi.org/10.1016/j.jos.2016.09.003

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the LURM (Laboratorio Universitario di Ricerca Medica) Research Center, University of Verona, especially Eliana Amato for performing the biochemical analyses.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

AF, LI, DG, and MR analyzed and interpreted the data. ES, DS, and EB gathered the data. GA and RD assessed the densitometric images and RN assessed the X-rays. AF drafted the manuscript and GT, OV, AG, GA, and AM significantly contributed to the discussion. All authors revised the manuscript and approved the final draft.

Corresponding author

Correspondence to Angelo Fassio.

Ethics declarations

Conlfict of interest

Angelo Fassio reports personal fees from Abiogen, Novartis, and Neopharmed, outside the submitted work. Luca Idolazzi reports personal fees from Eli-Lilly, Merck Sharp & Dohme, Novartis, Sanofi, Celgene, and UCB outside the submitted work. Maurizio Rossini reports personal fees from AbbVie, Abiogen, Eli-Lilly, Merck Sharp & Dohme, Novartis, Sanofi, and UCB, outside the submitted work. Davide Gatti has received advisory board honoraria, consultancy fees, and/or speaker fees from Abiogen, Celgene, Eli-Lilly, Neopharmed-Gentili, Pfizer, and UCB. All other authors do not have anything to disclose.

Ethical Approval

The study was conducted within the protocol 1483CESC approved by our local Ethics Committee, in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Written informed consent was obtained from all participants included.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fassio, A., Adami, G., Idolazzi, L. et al. Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Type 2 Diabetes: A New Imaging Possibility and a New Biomarker. Calcif Tissue Int 108, 231–239 (2021). https://doi.org/10.1007/s00223-020-00768-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-020-00768-2

Keywords

Navigation